Skip to content

Clinical trials

Phase 2 Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: China Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20103
20112
20122
20135
20145
20154
20162
20175
20187
20193
20206
20213
20226
20239
20248
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status29
Completed25
Recruiting22
Active, not recruiting7
Not yet recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University4
Shenzhen Hornetcorn Bio-technology Company, LTD4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3
Pfizer3
Sun Yat-sen University3
Tianjin Medical University Cancer Institute and Hospital3
Amgen2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
Chinese Academy of Medical Sciences2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms89
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms8
Digestive System Neoplasms7
Neoplasm Metastasis6
Neoplasms by Site6
Lung Neoplasms5
Esophageal Neoplasms4
Gastrointestinal Diseases4
Breast Neoplasms3

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.